Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Whitehawk Therapeutics (WHWK) over the last 4 years, with Q3 2025 value amounting to $2.0 million.

  • Whitehawk Therapeutics' Change in Acquisitions & Divestments fell 8685.61% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year decrease of 5115.82%. This contributed to the annual value of $63.3 million for FY2024, which is 5822.5% down from last year.
  • As of Q3 2025, Whitehawk Therapeutics' Change in Acquisitions & Divestments stood at $2.0 million, which was down 8685.61% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Whitehawk Therapeutics' Change in Acquisitions & Divestments peaked at $51.2 million during Q2 2023, and registered a low of $2.0 million during Q3 2025.
  • For the 4-year period, Whitehawk Therapeutics' Change in Acquisitions & Divestments averaged around $20.6 million, with its median value being $15.5 million (2024).
  • Per our database at Business Quant, Whitehawk Therapeutics' Change in Acquisitions & Divestments surged by 4401.57% in 2023 and then plummeted by 8685.61% in 2025.
  • Whitehawk Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $12.8 million in 2022, then skyrocketed by 44.02% to $18.4 million in 2023, then decreased by 27.47% to $13.3 million in 2024, then plummeted by 85.0% to $2.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $2.0 million in Q3 2025, compared to $3.4 million in Q2 2025 and $14.7 million in Q1 2025.